|Bid||87.89 x 900|
|Ask||88.18 x 900|
|Day's Range||86.53 - 88.40|
|52 Week Range||38.44 - 88.40|
|Beta (5Y Monthly)||0.38|
|PE Ratio (TTM)||33.35|
|Earnings Date||Nov 05, 2020 - Nov 09, 2020|
|Forward Dividend & Yield||0.78 (0.91%)|
|Ex-Dividend Date||May 15, 2020|
|1y Target Est||92.00|
Applied Dna Sciences shows improving price performance, earning an upgrade to its IBD Relative Strength Rating.
Sturm Ruger saw its IBD SmartSelect Composite Rating rise to 97 Tuesday, up from 94 the day before. The upgrade means the stock currently tops 97% of all other stocks in terms of key performance metrics and technical strength.
Shares of Sturm Ruger & Co (NYSE:RGR) fell 4.54% in after-market trading after the company reported Q2 results.Quarterly Results Earnings per share rose 200.00% year over year to $1.05, which missed the estimate of $1.23.Revenue of $130,264,000 rose by 35.23% from the same period last year, which missed the estimate of $167,060,000.Guidance Earnings guidance hasn't been issued by the company for now.View more earnings on RGRSturm Ruger & Co hasn't issued any revenue guidance for the time being.Price Action 52-week high: $80.5052-week low: $38.44Price action over last quarter: Up 42.59%Company Overview Sturm Ruger & Co Inc is engaged in the designing, manufacturing, and sale of firearms mainly to American customers. The company has two reportable operating segments: firearms and castings. It generates maximum revenue from firearms segment. The company offers products in three industry product categories, they are rifles, pistols, and revolvers. It also manufactures and sells investment castings made from steel alloys and metal injection molding.See more from Benzinga * Stocks That Hit 52-Week Highs On Wednesday * Earnings Scheduled For July 29, 2020 * Stocks That Hit 52-Week Highs On Monday(C) 2020 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.